# US 2021/0330378 A1 · Bilateral renal neuromodulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330378 A1
- Document ID: US20210330378A1
- Status: Published application
- Kind: A1
- Application number: 17/365,868
- Filed: 2021-07-01
- Published: 2021-10-28
- Earliest claimed: 2006-03-06
- Assignees: Medtronic Ardian Luxembourg S.a.r.l.
- Applicants: Medtronic Ardian Luxembourg S.a.r.l.
- Inventors: Denise Zarins; Hanson Gifford, III; Mark E. Deem; Douglas Sutton; Howard R. Levin; Mark Gelfand
- Web page: https://patentgrep.com/patent/US20210330378A1

## CPC

- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61F 7/12: Devices for heating or cooling internal body cavities
- A61M 5/14276: {specially adapted for implantation}
- A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence)
- A61N 1/327: {for enhancing the absorption properties of tissue, e.g. by electroporation}
- A61N 1/36017: {with leads or electrodes penetrating the skin}
- A61N 1/36117: {for treating hypertension}
- A61N 1/36121: {Production of neurotransmitters; Modulation of genes expression}
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61N 7/02: Localised ultrasound hyperthermia
- A61B 2018/0022: {Balloons}
- A61B 2018/00267: {having a basket shaped structure}
- A61B 2018/00351: {Heart}
- A61B 2018/00404: {Blood vessels other than those in or around the heart}
- A61B 2018/00434: {Neural system}
- A61B 2018/00511: {Kidney}
- A61B 2018/00577: {Ablation}
- A61B 2018/00613: {Irreversible electroporation}
- A61F 2007/126: {for invasive application, e.g. for introducing into blood vessels}
- A61M 2210/1082: Kidney
- A61M 2210/12: Blood circulatory system
- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61N 2007/0021: {Neural system treatment}
- A61N 2007/003: {Destruction of nerve tissue}
- A61N 2007/025: {interstitial}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim at position 2

21: A method comprising:
intravascularly advancing a catheter comprising a neuromodulation element through a guide catheter and over a guidewire to a first position within a first renal artery associated with a first kidney of a patient;
modulating a function of a first renal nerve adjacent to the first renal artery using the neuromodulation element;
retracting the catheter into the guide catheter;
repositioning the guide catheter and the guidewire into a second renal artery associated with a second kidney of the patient;
re-advancing the catheter through the guide catheter and over the guidewire to a second position within the second renal artery; and
modulating a function of a second renal nerve adjacent to the second renal artery using the neuromodulation element.

### Claim at position 3 (depends on 21)

22: The method of claim 21, wherein repositioning the guide catheter and guidewire comprises rotating the guide catheter to orient a distal portion of the guide catheter toward the second renal artery.

### Claim at position 4 (depends on 22)

23: The method of claim 22, wherein the distal portion of the guide catheter comprises a pre-formed shape.

### Claim at position 5 (depends on 21)

24: The method of claim 21, further comprising, after intravascularly advancing the catheter through the guide catheter and over the guidewire to the first position within the first renal artery and before modulating the function of the first renal nerve, expanding a centering element into contact with a wall of the first renal artery.

### Claim at position 6 (depends on 24)

25: The method of claim 24, wherein the centering element comprises at least one of a balloon or an expandable wire basket.

### Claim at position 7 (depends on 24)

26: The method of claim 24, further comprising, after modulating the function of the first renal nerve and before retracting the catheter into the guide catheter, collapsing the centering element to a reduced delivery profile.

### Claim at position 8 (depends on 21)

27: The method of claim 21, further comprising, after re-advancing the catheter through the guide catheter and over the guidewire to the second position within the second renal artery and before modulating the function of the second renal nerve, expanding a centering element into contact with a wall of the second renal artery.

### Claim at position 9 (depends on 27)

28: The method of claim 27, wherein the centering element comprises at least one of a balloon or an expandable wire basket.

### Claim at position 10 (depends on 21)

29: The method of claim 21, further comprising, prior to re-advancing the catheter through the guide catheter and over the guidewire to the second position within the second renal artery, re-advancing the guidewire through the guide catheter to the second renal artery.

### Claim at position 11 (depends on 21)

30: The method of claim 21, wherein retracting the catheter into the guide catheter comprises retracting the catheter and the guidewire into the guide catheter.

### Claim at position 12 (depends on 21)

31: The method of claim 21, further comprising, after intravascularly advancing the catheter through the guide catheter and over the guidewire to the first position within the first renal artery and before modulating the function of the first renal nerve, retracting the guidewire into the guide catheter.

### Claim at position 13 (depends on 21)

32: The method of claim 21, further comprising, after re-advancing the catheter through the guide catheter and over the guidewire to the second position within the second renal artery and before modulating the function of the second renal nerve, retracting the guidewire into the guide catheter.

### Claim at position 14 (depends on 21)

33: The method of claim 21, wherein modulating the function of the first renal nerve comprises delivering a drug to the first renal nerve via the neuromodulation element.

### Claim at position 15 (depends on 21)

34: The method of claim 21, wherein modulating the function of the first renal nerve comprises delivering ultrasound to the first renal nerve via the neuromodulation element.

### Claim at position 16 (depends on 21)

35: The method of claim 21, wherein modulating the function of the first renal nerve comprises delivering a pulsed electric field to the first renal nerve via the neuromodulation element.

### Claim at position 17 (depends on 21)

36: The method of claim 21, wherein modulating the function of the first renal nerve comprises delivering thermal energy to the first renal nerve via the neuromodulation element.

### Claim at position 18 (depends on 21)

37: The method of claim 21, wherein modulating the function of the first renal nerve comprises delivering a stimulation electric field to the first renal nerve via the neuromodulation element.

### Claim at position 19 (depends on 21)

38: The method of claim 21, wherein modulating the function of the first renal nerve comprises delivering a radio frequency waveform to the first renal nerve via the neuromodulation element.

### Claim at position 20

39: A method comprising:
intravascularly advancing a catheter comprising a neuromodulation element through a guide catheter and over a guidewire to a first position within a first renal artery associated with a first kidney of a patient, wherein the catheter comprises a neuromodulation element;
modulating a function of a first renal nerve adjacent to the first renal artery by at least delivering a drug, ultrasound, a pulsed electric field, thermal energy, electrical stimulation, or a radio frequency waveform to the first renal nerve via the neuromodulation element;
after modulating the function of the first renal nerve, retracting the catheter into the guide catheter;
after retracting the catheter into the guide catheter, repositioning the guidewire into a second renal artery associated with a second kidney of the patient;
repositioning the guide catheter into the second renal artery, wherein repositioning the guide catheter comprises rotating the guide catheter to orient a distal portion of the guide catheter toward the second renal artery;
re-advancing the catheter through the guide catheter and over the guidewire to a second position within the second renal artery; and
modulating a function of a second renal nerve adjacent to the second renal artery using the neuromodulation element.
